Fidelity Investments’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3,450
| Closed | -$4.49K | – | 5370 |
|
|
2025
Q2 | $4.49K | Sell |
3,450
-6,175
| -64% | -$7.43K | ﹤0.01% | 4731 |
|
|
2025
Q1 | $13.4K | Buy |
9,625
+5,396
| +128% | +$11.8K | ﹤0.01% | 4385 |
|
|
2024
Q4 | $9.68K | Buy |
4,229
+1,398
| +49% | +$3.7K | ﹤0.01% | 4473 |
|
|
2024
Q3 | $7.7K | Buy |
2,831
+1,404
| +98% | +$3.43K | ﹤0.01% | 4511 |
|
|
2024
Q2 | $3.34K | Sell |
1,427
-1,102
| -44% | -$3.52K | ﹤0.01% | 4636 |
|
|
2024
Q1 | $11.9K | Sell |
2,529
-549
| -18% | -$2.85K | ﹤0.01% | 4210 |
|
|
2023
Q4 | $15K | Sell |
3,078
-640
| -17% | -$2.66K | ﹤0.01% | 4082 |
|
|
2023
Q3 | $17.3K | Buy |
3,718
+2,903
| +356% | +$16.7K | ﹤0.01% | 3879 |
|
|
2023
Q2 | $6.02K | Sell |
815
-78,019
| -99% | -$521K | ﹤0.01% | 4308 |
|
|
2023
Q1 | $645K | Buy |
78,834
+346
| +0.4% | +$3.62K | ﹤0.01% | 2615 |
|
|
2022
Q4 | $751K | Sell |
78,488
-557
| -0.7% | -$6.85K | ﹤0.01% | 2611 |
|
|
2022
Q3 | $929K | Buy |
79,045
+150
| +0.2% | +$1.98K | ﹤0.01% | 2624 |
|
|
2022
Q2 | $1.01M | Sell |
78,895
-225
| -0.3% | -$2.33K | ﹤0.01% | 2672 |
|
|
2022
Q1 | $869K | Buy |
79,120
+346
| +0.4% | +$4.01K | ﹤0.01% | 2819 |
|
|
2021
Q4 | $1.21M | Sell |
78,774
-314,926
| -80% | -$4.12M | ﹤0.01% | 2651 |
|
|
2021
Q3 | $5.5M | Sell |
393,700
-4,600
| -1% | -$76.9K | ﹤0.01% | 2333 |
|
|
2021
Q2 | $7.7M | Buy |
+398,300
| New | +$8.22M | ﹤0.01% | 2204 |
|
Fidelity Investments's AKYA Position: Q3 2025 in Review
Fidelity Investments sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 3,450 shares — an estimated $4.49K sold.
Fidelity Investments first reported a position in AKYA in Q2 2021 and held it in 17 quarters. The position peaked at $7.7M in Q2 2021. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.
- Fidelity Investments reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
- Fidelity Investments sold 3,450 Akoya BioSciences shares in Q3 2025, an estimated $4.49K.
- Fidelity Investments first reported a position in Akoya BioSciences in Q2 2021 and held it in 17 quarters.
- Fidelity Investments's Akoya BioSciences position peaked at $7.7M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.
Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.